The concentrations of CCL2/MCP-1 and CXCL10/IP-10 were significantly higher in the CHIKV-infected patients during the acute phase of the disease in comparison to HD and patients in the chronic phase (Figure 4a,c). This evidence concerns the gene CXCL10 and Huntington disease.